P. Urban

发表

Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model.

S. Pocock, S. Saito, M. Krucoff, 2021, JAMA cardiology.

Impact of a nationwide public campaign on delays and outcome in Swiss patients with acute coronary syndrome

B. Seifert, P. Erne, P. Urban, 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Impact of changing definitions for myocardial infarction: a report from the AMIS registry.

S. Windecker, P. Erne, J. Stauffer, 2008, The American journal of medicine.

Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland

B. Seifert, P. Erne, M. Roffi, 2017, Open Heart.

2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.

S. Pocock, A. Íñiguez, M. Morice, 2017, Journal of the American College of Cardiology.

Registry results on 20 290 patients from the AMIS Plus in patients with acute coronary syndromes : Gender differences in management and outcomes

P. Erne, J. Gaspoz, P. Urban, 2007 .

Prevalence of Subclinical Rheumatic Heart Disease in Eastern Nepal: A School-Based Cross-sectional Study.

P. Jüni, T. Pilgrim, P. Urban, 2016, JAMA cardiology.

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS).

M. Bertrand, A. Gershlick, P. Urban, 2000, Circulation.

Early Drug Therapy and In-Hospital Mortality following Acute Myocardial Infarction

F. Gutzwiller, P. Erne, J. Stauffer, 2003, Heart Drug.

Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry

P. Erne, J. Gaspoz, P. Urban, 2005, Heart.

year results from a nationwide registry elevation myocardial infarction in Switzerland: six Trends in reperfusion therapy of ST segment

P. Erne, J. Gaspoz, P. Urban, 2005 .

Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial.

A. Íñiguez, I. Durand-zaleski, M. Morice, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial.

M. Morice, P. Urban, P. Brunel, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Polymer-free Drug-Coated Coronary Stents.

F. Eberli, S. Pocock, A. Íñiguez, 2016, The New England journal of medicine.

Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.

T. Lüscher, P. Erne, M. Jaguszewski, 2014, International journal of cardiology.

Why are we still using coronary bare-metal stents?

G. Schuler, M. Morice, P. Urban, 2013, Journal of the American College of Cardiology.

Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse?

F. Eberli, S. Windecker, T. Lüscher, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

STEMI and PCI in Switzerland 2000-2010. Pre-hospital delay and door-to-balloon time

P. Erne, P. Urban, H. Rickli, 2011 .

Design and rationale of a randomized trial of COBRA PzF stenting to REDUCE duration of triple therapy (COBRA-REDUCE).

A. Kirtane, R. Jauhar, M. Joner, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.

Deepak L. Bhatt, Sunil V. Rao, S. Pocock, 2020, Journal of the American College of Cardiology.

Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy.

M. Morice, K. Oldroyd, P. Urban, 2017, JACC. Cardiovascular interventions.

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study

S. Pocock, M. Morice, P. Urban, 2016, European heart journal.

Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial.

F. Eberli, A. Zaman, M. Morice, 2017, International journal of cardiology.

Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention.

A. Zaman, N. Curzen, Y. Loke, 2016, The American journal of cardiology.

Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients

P. Laanmets, R. Piccolo, W. Wijns, 2016, Heart.

Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents

Sunil V. Rao, M. Price, S. Pocock, 2020, Circulation. Cardiovascular interventions.

Outcome of patients admitted with acute coronary syndrome on palliative treatment: insights from the nationwide AMIS Plus Registry 1997–2014

B. Seifert, P. Erne, P. Urban, 2015, BMJ Open.

Multisite vascular disease in acute coronary syndromes: increased in-hospital mortality and no improvement over time

F. Eberli, P. Erne, M. Roffi, 2020, European heart journal. Acute cardiovascular care.

Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world.

P. Urban, A. Bloch, M. Zimmermann, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Treatment and outcomes of patients with recurrent myocardial infarction: A prospective observational cohort study.

P. Erne, J. Stauffer, P. Urban, 2016, Journal of cardiology.

Acute coronary syndromes in young patients: presentation, treatment and outcome.

F. Gutzwiller, S. Windecker, A. Schoenenberger, 2011, International journal of cardiology.

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.

M. Jeong, F. Neumann, S. Ellis, 2013, International journal of cardiology.

Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.

Samin K. Sharma, M. Krucoff, G. Dangas, 2020, Journal of the American College of Cardiology.

Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry.

M. Jeong, F. Neumann, S. Ellis, 2011, Journal of the American College of Cardiology.

Outcome of patients with acute coronary syndrome in hospitals of different sizes. A report from the AMIS Plus Registry.

F. Gutzwiller, B. Seifert, P. Erne, 2010, Swiss medical weekly.

Left bundle‐branch block in patients with acute myocardial infarction: Presentation, treatment, and trends in outcome from 1997 to 2016 in routine clinical practice

F. Eberli, P. Erne, P. Urban, 2017, American heart journal.

Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials

M. Pfisterer, L. Sleeper, C. Tseng, 2011, Acute cardiac care.

F. Eberli, F. Gutzwiller, S. Windecker, 2008, Journal of the American Geriatrics Society.

Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock

M. Pfisterer, P. Erne, P. Hunziker, 2008, Annals of Internal Medicine.

Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry.

M. Jeong, F. Neumann, S. Ellis, 2011, JACC. Cardiovascular interventions.

C-reactive protein as a marker for acute coronary syndromes.

W. Rutishauser, C. Lovis, F. Mach, 1997, European heart journal.

Confirming the validity of the ARC-HBR criteria in patients presenting with ACS: the first step in reducing bleeding risk.

P. Urban, R. Colleran, 2022, Revista espanola de cardiologia.

Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk.

S. Pocock, L. Räber, S. Windecker, 2020, European heart journal.

Validation of Standardization: Testing the Academic Research Consortium High Bleeding Risk Criteria.

D. Cutlip, P. Urban, 2019, Circulation. Cardiovascular Interventions.

Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011

F. Eberli, B. Seifert, S. Windecker, 2012, European heart journal. Acute cardiovascular care.

Is Pretreatment with Beta-Blockers Beneficial in Patients with Acute Coronary Syndrome?

P. Erne, P. Urban, G. Pedrazzini, 2009, Cardiology.

Validation of a Multicenter Registry Database of Intra-Aortic Balloon Pumping in a Variety of Clinical Settings

J. Christenson, E. Ohman, G. Stone, 2003, Heart Drug.

Significant decrease in in-hospital mortality and major adverse cardiac events in Swiss STEMI patients between 2000 and December 2007.

P. Erne, J. Stauffer, J. Goy, 2009, Swiss medical weekly.

Impact of a normal or non-specific admission ECG on the treatment and early outcome of patients with myocardial infarction in Swiss hospitals between 2003 and 2008.

F. Gutzwiller, B. Seifert, P. Erne, 2010, Swiss medical weekly.

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry.

M. Jeong, F. Neumann, D. Holmes, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

HIV/AIDS in China: the numbers problem

P. Urban, E. Benedetti, 2007 .

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.

F. Neumann, S. Ellis, D. Holmes, 2012, JACC: Cardiovascular Interventions.

Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial

M. Morice, P. Urban, F. Krackhardt, 2020, Clinical Research in Cardiology.

Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry.

J. Christenson, E. Ohman, G. Stone, 2003, European heart journal.

The veteran and the rookie.

P. Urban, 2005, European heart journal.

Sex‐Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria

S. Pocock, L. Räber, S. Windecker, 2021, Journal of the American Heart Association.

Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry

F. Eberli, S. Cook, S. Windecker, 2019, Circulation. Cardiovascular interventions.

European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.

S. Windecker, T. Walther, H. Baumgartner, 2015, JACC. Cardiovascular interventions.

Polymer-free drug-coated coronary stents in diabetic patients at high bleeding risk: a pre-specified sub-study of the LEADERS FREE trial

A. Íñiguez, D. Foley, M. Morice, 2018, Clinical Research in Cardiology.

F. Eberli, S. Windecker, P. Erne, 2013, European heart journal. Acute cardiovascular care.

[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC].

G. Stone, S. Silber, A. Colombo, 2005, Kardiologia polska.

Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients

R. Bellomo, A. Mebazaa, F. Zannad, 2018, Intensive Care Medicine.

Polymer‐free Biolimus‐A9 coated thin strut stents for patients at high bleeding risk 1‐year results from the LEADERS FREE III study

F. Eberli, S. Cook, M. Morice, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy.

S. Pocock, M. Morice, P. Urban, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Drug‐Eluting or Bare‐Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization

P. Serruys, L. Räber, E. Ribeiro, 2021, Journal of the American Heart Association.

Rapid bedside whole blood cardiospecific troponin T immunoassay for the diagnosis of acute myocardial infarction.

C. Lovis, J. Chevrolet, F. Mach, 1995, The American journal of cardiology.

Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention

S. Pocock, T. Henry, M. Krucoff, 2020, Circulation. Cardiovascular interventions.

PTCA versus CABG: a different interpretation of the results of randomised trials comparing both treatments

N. Danchin, P. Urban, 1999, Heart.

Individual Patient Data Meta-analysis of Drug-eluting Versus Bare-metal Stents for Percutaneous Coronary Intervention in Chronic Versus Acute Coronary Syndromes.

E. Ribeiro, P. Jüni, S. Windecker, 2022, The American journal of cardiology.

Impact of vascular access on outcome after PCI in patients at high bleeding risk: a pre-specified sub-analysis of the LEADERS FREE trial.

A. Íñiguez, M. Morice, P. Urban, 2020, Revista espanola de cardiologia.

[Invasive pulmonary aspergillosis associated with an acute influenza virus infection].

J. Chevrolet, P. Urban, J. Cox, 1985, Revue des maladies respiratoires.

In-hospital mortality associated with the use of intra-aortic balloon counterpulsation.

J. Christenson, E. Ohman, G. Stone, 2004, The American journal of cardiology.

One‐year clinical outcomes after sirolimus‐eluting coronary stent implantation in diabetics enrolled in the worldwide e‐SELECT registry

F. Neumann, S. Ellis, D. Holmes, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients.

Sunil V. Rao, S. Pocock, M. Krucoff, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

One-year outcome of small-vessel disease treated with sirolimus-eluting stents: a subgroup analysis of the e-SELECT registry.

M. Jeong, S. Ellis, V. Džavík, 2013, Journal of interventional cardiology.

delay in patients reporting chest pain . Impact of a public campaign on pre-hospital

L. Goldman, W. Rutishauser, C. Lovis, 2022 .

Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice

B. Seifert, P. Erne, T. Pilgrim, 2017, Journal of cardiovascular medicine.

Impact of Clinical Presentation on Bleeding Risk after Percutaneous Coronary Intervention and Implications for the ARC-HBR Definition.

S. Pocock, L. Räber, S. Windecker, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery.

J. Christenson, E. Ohman, G. Stone, 2002, The Annals of thoracic surgery.

Multicenter aspirin and ticlopidine trial after intracoronary stenting in high risk patients

C. Macaya, P. Urban, H. Rupprecht, 1998 .

Rheumatic heart disease revisited: patterns of valvular involvement from a consecutive cohort in eastern Nepal

T. Pilgrim, P. Urban, S. Dhakal, 2012, Journal of cardiovascular medicine.

Protocol for a population-based study of rheumatic heart disease prevalence and cardiovascular outcomes among schoolchildren in Nepal

B. Meier, T. Pilgrim, P. Urban, 2012, BMJ Open.

Polymer-free Drug-Coated Coronary Stents.

M. Morice, P. Urban, 2016, The New England journal of medicine.

Early and late Q wave regression in the setting of acute myocardial infarction

J. Sztajzel, P. Urban, 2000, Heart.

862-2 Sirolimus-eluting stent implantation in routine clinical practice: A 12-month follow-up report from the international eCYPHER registry

P. Guyon, G. Guagliumi, A. Gershlick, 2004 .

Rheumatic heart disease: pilot study for a population-based evaluation of prevalence and cardiovascular outcomes among schoolchildren in Nepal

T. Pilgrim, P. Urban, B. Kalesan, 2012, BMJ Open.

Effects of Transcendental Meditation on Symptoms and Electrocardiographic Changes in Patients With Cardiac Syndrome X

P. Teirstein, M. Leon, R. Schatz, 2000 .

Inpatient versus outpatient onsets of acute myocardial infarction.

T. Lüscher, P. Erne, P. Urban, 2015, European journal of internal medicine.

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

C. Macaya, P. Urban, H. Rupprecht, 1998, Circulation.

Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon.

P. Urban, A. Bloch, S. Kingue, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012

F. Eberli, B. Seifert, M. Puhan, 2013, Heart.

Characteristics and Outcome in Acute Coronary Syndrome Patients with and without Established Modifiable Cardiovascular Risk Factors: Insights from the Nationwide AMIS Plus Registry 1997–2010

F. Gutzwiller, P. Erne, P. Urban, 2012, Cardiology.

Presentation and outcome of patients with acute coronary syndromes in eastern Nepal.

B. Meier, T. Pilgrim, P. Urban, 2011, Swiss medical weekly.

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

M. Price, S. Pocock, N. Stockbridge, 2019, European heart journal.

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

M. Price, S. Pocock, N. Stockbridge, 2019, Circulation.

Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry

P. Erne, J. Gaspoz, P. Urban, 2007, Heart.

Registryon 20 290 patients from the AMIS Plus in patients with acute coronary syndromes: Gender differences in management and outcomes

P. Erne, P. Urban, H. Rickli, 2007 .

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Antonio Colombo, Erik Jørgensen, Per Albertsson, 2005, European heart journal.

Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary Stent: The European evaLUation of pacliTaxel Eluting Stent (ELUTES) Trial

A. Heldman, J. Brinker, A. Gershlick, 2004, Circulation.

Acute myocardial infarction.

N. Danchin, P. Urban, E. de Benedetti, 2003, Clinical evidence.

[Guidelines for percutaneous coronary interventions].

Antonio Colombo, Erik Jørgensen, Per Albertsson, 2005, Revista espanola de cardiologia.

Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry.

J. Christenson, E. Ohman, G. Stone, 2003, Journal of the American College of Cardiology.

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials

P. Serruys, L. Räber, E. Ribeiro, 2019, The Lancet.

Impact of a public campaign on pre-hospital delay in patients reporting chest pain.

L. Goldman, W. Rutishauser, C. Lovis, 1996, Heart.

Stents and antiplatelet therapy.

P. Urban, A. Fassa, 2012, Advances in cardiology.

Impact of comorbidities on clinical presentation, management and outcome of patients with acute coronary syndrome

F. Eberli, P. Erne, J. Stauffer, 2010 .

A multicentre European registry of intraluminal coronary beta brachytherapy.

P. Serruys, S. Silber, P. Serruys, 2003, European heart journal.

Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses.

G. Stone, A. Kirtane, F. Gaita, 2013, International journal of cardiology.

Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice: One-Year Follow-Up of the e-Cypher Registry

Fesc, P. Guyon, J. E. Sousa, 2006, Circulation.

Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience.

F. Eberli, S. Windecker, P. Erne, 2011, JACC. Cardiovascular interventions.

Predicting mortality from change-over-time in the Charlson Comorbidity Index

I. Buchan, N. Peek, E. Kontopantelis, 2016, Medicine.

Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry

F. Eberli, P. Erne, J. Stauffer, 2017, Clinical cardiology.

Low prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland.

M. Costanza, J. Gaspoz, S. Beer-Borst, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial.

R. Mehran, M. Morice, J. Chandrasekhar, 2020, JAMA cardiology.

Polymers and coronary stents: have we come full circle?

P. Urban, B. Chevalier, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Outcomes following implantation of the biolimus A9‐eluting BioMatrix coronary stent: Primary analysis of the e‐BioMatrix registry

F. Eberli, I. Menown, M. Roffi, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of neointimal formation in polymer-free paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials).

Seung‐Jung Park, C. Vrints, N. Fearnot, 2004, The American journal of cardiology.

Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice.

J. Goy, P. Urban, E. de Benedetti, 2009, American heart journal.

Comparison of in-hospital mortality for acute myocardial infarction in Switzerland with admission during routine duty hours versus admission during out of hours (insight into the AMIS plus registry).

P. Erne, J. Stauffer, P. Urban, 2008, The American journal of cardiology.

Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy.

S. Pocock, M. Morice, I. Meredith, 2013, American heart journal.

Drug-eluting stents compared to bare-metal stents improve short-term survival in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a nationwide prospective analysis of the AMIS Plus registry.

P. Erne, B. Nallamothu, M. Jaguszewski, 2014, Kardiologia polska.

Bleeding avoidance strategies in percutaneous coronary intervention

Deepak L. Bhatt, S. Windecker, R. Mehran, 2021, Nature Reviews Cardiology.

Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study).

I. Buchan, N. Peek, P. Urban, 2015, The American journal of cardiology.

A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.

R. Whitbourn, P. Fitzgerald, F. Neumann, 2008, JACC. Cardiovascular interventions.

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.

W. Wijns, P. Urban, B. Chevalier, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Correction to: Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients

R. Bellomo, A. Mebazaa, F. Zannad, 2018, Intensive Care Medicine.

Thrombosis: the last frontier of coronary stenting?

P. Urban, E. Benedetti, 2007, The Lancet.

Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.

M. Morice, K. Bogaerts, P. Urban, 2023, American heart journal.

Randomized , Controlled , Multicenter Trial to valuate the Safety and Efficacy of Zotarolimus-ersus Paclitaxel-Eluting Stents in De Novo cclusive Lesions in Coronary Arteries

R. Whitbourn, P. Fitzgerald, F. Neumann, 2008 .

A novel ultra-thin bare metal stent (BMS): results from a worldwide registry.

P. Guyon, R. Kornowski, B. Nowak, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registry.

S. Ellis, V. Džavík, P. Urban, 2012, Journal of interventional cardiology.

Use of sirolimus‐eluting coronary stents in routine clinical practice

J. Stauffer, J. Goy, P. Urban, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Percutaneous coronary intervention for acute coronary syndromes in eastern Nepal: a preliminary report.

S. Cook, T. Pilgrim, P. Urban, 2013, Swiss medical weekly.

Very severe self-poisoning lithium carbonate intoxication causing a myocardial infarction.

J. Chevrolet, P. Urban, A. Perrier, 1991, Chest.

A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus- Versus Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries: The ZoMaxx I Trial

R. Whitbourn, P. Fitzgerald, David O. Williams, 2008 .

Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.

P W Serruys, R Simon, P. Serruys, 1996, Journal of the American College of Cardiology.

Coronary stenting: why size matters

P. Urban, E. de Benedetti, 2006, Heart.

Cardiac arrest and blood ionized calcium levels.

P. Urban, P. Urban, D. Scheidegger, 1988, Annals of internal medicine.